Literature DB >> 15161684

p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy.

Stephanie Si Liu1, Rebecca Ching-Yu Leung, Kelvin Yuen-Kwong Chan, Pui-Man Chiu, Annie Nga-Yin Cheung, Kar-Fai Tam, Tong-Yow Ng, Ling-Chui Wong, Hextan Yuen-Sheung Ngan.   

Abstract

Apoptosis is one of the causes of cell death in cervical cancer following radiotherapy. By studying the gene expression profile with cDNA apoptotic array, the p73 gene was found overexpressed in radiosensitive cervical cancers when compared with radioresistant ones. To investigate the role of the p73 gene in relation to clinical assessment of radiosensitivity in cervical cancer based on the findings of residual tumor cells in cervical biopsies after completion of radiotherapy, we studied the protein expression of p73 in 59 cervical cancers after radiotherapy and 68 normal cervices using immunohistochemistry. The expression of p73 was found to be significantly increased in cancer samples and, more importantly, in those samples sensitive to radiotherapy (P < 0.001). The overexpression of p73 actually predicted a better prognosis in cervical cancer patients (P < 0.001). To investigate the possible involvement of p73 downstream genes, the protein expressions of p21 and Bax were studied. The expression of p21, but not Bax, was found to be positively correlated with the expression of p73 (P = 0.001). Furthermore, the epigenetic regulation of p73 expression via DNA methylation was also investigated in 103 cervical cancers and 124 normals. Hypermethylation of p73 gene was observed in 38.8% of cervical cancers, and it was significantly associated with reduced or absent p73 expression (P < 0.001). Reactivation of p73 expression in two cervical cancer cell lines by demethylation treatment supported the role of methylation in the regulation of p73 expression. Our findings suggested that p73 expression was related to the radiosensitivity of cervical cancer cells and may play an important role in the regulation of cellular radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161684     DOI: 10.1158/1078-0432.CCR-03-0119

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  26 in total

1.  Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.

Authors:  Yintao Ye; Wenqing Xu; Wei Zhong; Yajing Li; Chen Wang
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population.

Authors:  Abhimanyu Kumar Jha; Mohsen Nikbakht; Veena Jain; Alka Sehgal; Neena Capalash; Jagdeep Kaur
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

3.  Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells.

Authors:  Daniella Pfeifer; Asa Wallin; Birgitta Holmlund; Xiao-Feng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-06       Impact factor: 4.553

4.  Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to gamma-irradiation.

Authors:  Xin-li Li; Qing-hui Meng; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2009-03-09       Impact factor: 6.150

5.  Recent findings on epigenetic gene abnormalities involved in uterine cancer.

Authors:  Megumi Yanokura; Kouji Banno; Yusuke Kobayashi; Hiroyuki Nomura; Shigenori Hayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2017-09-20

Review 6.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

7.  Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.

Authors:  Rob Noorlag; Pauline M W van Kempen; Cathy B Moelans; Rick de Jong; Laura E R Blok; Ronald Koole; Wilko Grolman; Paul J van Diest; Robert J J van Es; Stefan M Willems
Journal:  Epigenetics       Date:  2014-07-08       Impact factor: 4.528

Review 8.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 9.  DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art.

Authors:  Frank Roossink; Steven de Jong; G Bea A Wisman; Ate G J van der Zee; Ed Schuuring
Journal:  Cell Oncol (Dordr)       Date:  2012-07-27       Impact factor: 6.730

10.  Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells.

Authors:  Yeo Kyoung Oh; Hyun Jung Lee; Mi-Hee Jeong; Marie Rhee; Ji-Won Mo; Eun Hyeon Song; Joong-Yeon Lim; Kyung-Hee Choi; Inho Jo; Sang Ick Park; Bin Gao; Yongil Kwon; Won-Ho Kim
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.